Community acquired respiratory viral infections (CRV) can increase morbidity, mortality in some critical disease conditions like cancer.

These are the result of infections with a heterogeneous group of viruses including RNA viruses, such as respiratory syncytial virus (RSV), influenza virus (IV), parainfluenza virus (PIV), metapneumovirus (HMPV), rhinovirus (RhV), and coronavirus (CoV).

Infections due to recent COVID-19 outbreak maintain similar seasonal pattern to those of immunocompetent patients. Clinical manifestations vary significantly depending on type and degree of immunosuppression, from upper to lower respiratory tract infection and prolonged viral shedding.

Use of corticosteroids and immunosuppressive therapy are risk factors for severe diseaseer:

(Disclaimer: Raktim Chattopadhyay, Founder & CEO, Esperer Onco Nutrition. Views expressed are a personal opinion.)

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Disclaimer: The views and opinions expressed in this article are solely those of the author and do not necessarily reflect the official policy or views of any organisation. The content is intended for informational and educational purposes only and should not be construed as medical advice.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!